🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Acquiring Popularity Online

Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed fat-burning effects. Followers are encouraged to contact these profiles directly for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing market exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers promote the substance there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Voice Worries

Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting products of unknown origin.

Several professionals said the popularity for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.

Platform Reaction and Material Removal

According to TikTok, the service has removed problematic content and banned related hashtags and query recommendations. The company stated it was committed to keeping the platform safe and allocating resources in strengthening compliance measures.

Online Trading Activities

Research also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of users, filled with photos of slimming results, glowing testimonials and detailed guides for mixing or administering at residence.

After minutes of entering one community, a seller posted WhatsApp details, where most purchases take place. The seller sent an instruction manual and promised delivery within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, medical conditions or past usage.

Item Information and Pricing

Within these communities, posts display dark colored parcels with Royal Mail labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When questioned how much time a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for Telegram said it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting materials they can’t verify. Although the research behind retatrutide is sound, these digital products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But fake injections are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has previously seen patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company experimental product not yet authorized … may subject patients to possibly serious medical dangers”.